Home › Cytokine Release Syndrome › California
Cytokine Release Syndrome clinical trials in California
3 studies for Cytokine Release Syndrome are looking for participants at sites in California.
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
- Berenson Cancer Center, Los Angeles
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07609940Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Community Cancer Institute (CCI), Clovis
- Providence Medical Foundation, Fullerton
- Los Angeles Cancer Network, Glendale
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06806033Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
- University of California, Irvine - Chao Family Comprehensive Cancer Center, Orange
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05905328From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.